Cargando…
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
OBJECTIVE: Effective adjuvant therapeutic strategies are urgently needed to overcome MAPK inhibitor (MAPKi) resistance, which is one of the most common forms of resistance that has emerged in many types of cancers. Here, we aimed to systematically identify the genetic interactions underlying MAPKi r...
Autores principales: | Yu, Yu, Tao, Minzhen, Xu, Libin, Cao, Lei, Le, Baoyu, An, Na, Dong, Jilin, Xu, Yajie, Yang, Baoxing, Li, Wei, Liu, Bing, Wu, Qiong, Lu, Yinying, Xie, Zhen, Lian, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832956/ https://www.ncbi.nlm.nih.gov/pubmed/34106558 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0560 |
Ejemplares similares
-
PPy nanoneedle based nanoplatform capable of overcoming biological barriers for synergistic chemo-photothermal therapy
por: Yin, Yanyan, et al.
Publicado: (2020) -
Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
por: Reger de Moura, Coralie, et al.
Publicado: (2020) -
Synergistic action of RNA polymerases in overcoming the nucleosomal barrier
por: Jin, Jing, et al.
Publicado: (2010) -
Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
por: Paton, Emily L., et al.
Publicado: (2020) -
Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy
por: Li, Tongyu, et al.
Publicado: (2022)